NACDS collaborated with the Oklahoma Pharmacy Association to advance four critical PBM reform bills. SB 2074, which establishes a pharmacy reimbursement rate floor—setting NADAC plus a dispensing fee that cannot fall below the Medicaid fee-for-service rate for both commercial and state plans—was heard by the House Public Health Committee on April 8. The committee also considered two additional PBM reform bills, including SB 1500 and SB 2007. On April 7, the House Insurance Committee heard SB 1447. NACDS submitted letters voicing strong support for all four bills, which would implement essential PBM reforms.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

On March 26, the Senate passed SB 2074 by a decisive 34-3 vote. This bill aims to establish a reimbursement rate floor of NADAC plus a dispensing fee that cannot be lower than the Medicaid fee-for-service rate. The legislation was reported to the House for further consideration.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Legislature will convene on February 2 and is scheduled to adjourn on May 29.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The legislature convened an interim hearing to examine the influence of PBMs on prescription drug pricing and patient access to local pharmacies. Chaired by Sen. Spencer Kern (R) and pharmacist Rep. T.J. Marti (R), the session highlighted significant concerns regarding below-cost pharmacy reimbursements, opaque pricing structures and patient steering practices. Expert testimony by Antonio Ciaccia, 46brooklyn Research, and others underscored systemic incentives that diminish transparency and raise costs. The Attorney General’s office and the Insurance Department reported recovering $32 million through enforcement actions, positioning Oklahoma as a national leader in PBM oversight. Legislators signaled intent to pursue comprehensive PBM reform legislation again in 2026, aimed at enhancing transparency, safeguarding independent pharmacies and ensuring equitable drug pricing.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

On September 9, the Attorney General Gentner Drummond (R) announced a $32.1 million settlement with CVS Caremark, a PBM for the state's HealthChoice plan. The settlement resolves allegations that CVS Caremark withheld millions of dollars in drug rebates intended to reduce healthcare costs for state employees between January 2020 and December 2024. Approximately $27 million, after attorney fees, will be returned to HealthChoice within 30 days to benefit state employees, retirees and their families. The agreement also mandates quarterly rebate reporting, prompt rebate remittance and expanded definitions to ensure transparency and accountability.  

Also in Oklahoma, NACDS submitted the state survey on the Rural Health Transformation Program funds. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Board of Pharmacy posted the quarterly newsletter.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The US Supreme Court has declined to review the PCMA v. Mulready case, marking a significant setback for efforts to protect patients and pharmacies from harmful practices by PBMs. This decision upholds the 10th Circuit’s ruling, which struck down key provisions of the state’s Patient’s Right to Pharmacy Choice Act on the grounds that they are preempted by ERISA and Medicare Part D. As a result, the state now faces limited options for safeguarding pharmacies and ensuring patient access to the medications they need.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Kevin Stitt (R) appointed, and the Legislature confirmed Walmart pharmacist Shannon Griggs to serve a five-year term on the Board of Pharmacy, beginning July 1 and expiring June 30, 2030. Griggs is replacing Mark St. Cyr. 

Also in Oklahoma, SB 789, a PBM reform bill banning effective rate contracts, providing network transparency and reimbursement appeal protections, was enacted without Gov. Kevin Stitt's (R) signature. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Kevin Stitt (R) signed into law two bills of importance to pharmacies: 

• SB 806, the Food is Medicine bill, will improve access to essential nutrition services for Medicaid beneficiaries utilizing an 1115 waiver.  

• SB 906, legislation enhancing pharmacies' capacity to deliver essential pharmacy care services by increasing the current restrictive pharmacy technician to pharmacist ratio in retail pharmacies from 2:1 up to 4:1.  

Also in Oklahoma, Gov. Stitt (R) vetoed SB 773, legislation pharmacies supported that would give the Attorney General (AG) greater enforcement authority. In his veto message, the Governor accused the Attorney General of trying to grow his office and expand his authority, and that "he has shown again and again that he will abuse it". 

Also in Oklahoma, Gov. Stitt (R) selected, and the Senate officially confirmed the appointment of Walmart pharmacist, Shannon Griggs, to serve a five-year term on the Board of Pharmacy, succeeding Mark St. Cyr.  

Finally in Oklahoma, SB 789 that was amended in the House removing the rate floor language that triggered the $28M fiscal note, passed the Senate on May 21. The bill provides network transparency and reimbursement appeal protections. It was sent to the Governor's office. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.